232 related articles for article (PubMed ID: 12913962)
1. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
Huff B
GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
[No Abstract] [Full Text] [Related]
2. New protease inhibitor atazanavir (Reyataz) approved.
AIDS Treat News; 2003 Jun; (392):3. PubMed ID: 12913956
[No Abstract] [Full Text] [Related]
3. FDA notifications. Alternative dosing regimen for atazanavir is approved.
AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
[No Abstract] [Full Text] [Related]
4. Boosted Reyataz: 48-week results.
Huff B
GMHC Treat Issues; 2004; 18(1-2):15. PubMed ID: 15119279
[No Abstract] [Full Text] [Related]
5. Atazanavir background documents available.
AIDS Treat News; 2003 May; (391):3. PubMed ID: 12866495
[TBL] [Abstract][Full Text] [Related]
6. FDA notifications. Reyataz is approved for HIV treatment.
AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. Kaletra + atazanavir.
TreatmentUpdate; 2005; 17(5):5. PubMed ID: 17219657
[No Abstract] [Full Text] [Related]
8. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
9. Atazanavir (Reyataz).
Proj Inf Perspect; 2003 Oct; (36):7-10. PubMed ID: 14696568
[TBL] [Abstract][Full Text] [Related]
10. FDA notifications. FDA approves new atazanavir labeling.
AIDS Alert; 2011 Mar; 26(3):33-4. PubMed ID: 21539041
[No Abstract] [Full Text] [Related]
11. HIV therapeutics, continued: another HIV protease inhibitor approved.
Laurence J
AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
[No Abstract] [Full Text] [Related]
12. FDA notifications. Revised atazanavir package insert.
AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
[No Abstract] [Full Text] [Related]
13. [Interview with Professor Jürgen Rockstroh, director of the Bonn University Clinic. Atazanavir in general practice].
Rockstroh J
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():18-9. PubMed ID: 15373037
[No Abstract] [Full Text] [Related]
14. BMS-232632, a new protease inhibitor, is taken once daily.
Gaylord G
Posit Living; 2000 Jul; 9(6):22. PubMed ID: 12492017
[No Abstract] [Full Text] [Related]
15. Drug interactions. Kaletra and atazanavir.
TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
[No Abstract] [Full Text] [Related]
16. FDA notifications. Atazanavir capsule label is updated for pediatric patients.
AIDS Alert; 2008 May; 23(5):59-60. PubMed ID: 18637262
[No Abstract] [Full Text] [Related]
17. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
18. Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
TreatmentUpdate; 2009; 21(3):3-4. PubMed ID: 19623725
[No Abstract] [Full Text] [Related]
19. [New data on atazanavir/r]].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
Soriano V; García-Gasco P; Vispo E; Ruiz-Sancho A; Blanco F; Martín-Carbonero L; Rodríguez-Novoa S; Morello J; de Mendoza C; Rivas P; Barreiro P; González-Lahoz J
J Antimicrob Chemother; 2008 Jan; 61(1):200-5. PubMed ID: 17999977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
